Literature DB >> 22003335

Biomarkers and heart disease.

Michelle A Albert1.   

Abstract

This review will focus on the evaluation of biomarkers and surrogate endpoints in chronic disease risk with a focus on cardiovascular disease. It provides an example of how identification of relevant biomarkers might be useful in sleep research and clinical care. Much of this review is derived from work performed by the Institute of Medicine (IOM) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease (see footnote in the Acknowledgments). This discussion will review the committee charge, definitions of biomarkers and other endpoints, biomarker evaluation framework, case studies of representative biomarkers, recommendations, and conclusions.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22003335      PMCID： PMC3190417          DOI： 10.5664/JCSM.1342

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


  2 in total

1.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

2.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245
  2 in total
  7 in total

1.  Suppression of HDAC by sodium acetate rectifies cardiac metabolic disturbance in streptozotocin-nicotinamide-induced diabetic rats.

Authors:  Kehinde S Olaniyi; Oluwatobi A Amusa; Emmanuel D Areola; Lawrence A Olatunji
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-17

Review 2.  Towards a Multivariate Biomarker-Based Diagnosis of Autism Spectrum Disorder: Review and Discussion of Recent Advancements.

Authors:  Troy Vargason; Genevieve Grivas; Kathryn L Hollowood-Jones; Juergen Hahn
Journal:  Semin Pediatr Neurol       Date:  2020-03-05       Impact factor: 1.636

Review 3.  Improper Proteostasis: Can It Serve as Biomarkers for Neurodegenerative Diseases?

Authors:  Ankur Rakesh Dubey; Som Mohanlal Patwa; Sumit Kinger; Yuvraj Anandrao Jagtap; Prashant Kumar; Sarika Singh; Rohan Dhiman; Hem Chandra Jha; Amit Mishra
Journal:  Mol Neurobiol       Date:  2022-03-19       Impact factor: 5.682

4.  Simultaneous detection and quantification of DNA and protein biomarkers in spectrum of cardiovascular diseases in a microfluidic microbead chip.

Authors:  Franziska Dinter; Michał Burdukiewicz; Peter Schierack; Werner Lehmann; Jörg Nestler; Gregory Dame; Stefan Rödiger
Journal:  Anal Bioanal Chem       Date:  2019-11-23       Impact factor: 4.142

5.  No evidence of differential impact of sunflower and rapeseed oil on biomarkers of coronary artery disease or chronic kidney disease in healthy adults with overweight and obesity: result from a randomised control trial.

Authors:  Katie Nicol; Bahareh Mansoorian; Agnieszka Latosinska; Aimilia Koutroulaki; Bill Mullen; Emilie Combet
Journal:  Eur J Nutr       Date:  2022-04-05       Impact factor: 4.865

Review 6.  Metabolic biomarkers for predicting cardiovascular disease.

Authors:  Jana E Montgomery; Jeremiah R Brown
Journal:  Vasc Health Risk Manag       Date:  2013-01-29

Review 7.  Resting-State Functional Connectivity-Based Biomarkers and Functional MRI-Based Neurofeedback for Psychiatric Disorders: A Challenge for Developing Theranostic Biomarkers.

Authors:  Takashi Yamada; Ryu-Ichiro Hashimoto; Noriaki Yahata; Naho Ichikawa; Yujiro Yoshihara; Yasumasa Okamoto; Nobumasa Kato; Hidehiko Takahashi; Mitsuo Kawato
Journal:  Int J Neuropsychopharmacol       Date:  2017-10-01       Impact factor: 5.176
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.